EIS-12656

N/A

Report date: 2024/07/30 20:00:05
NME

Base Information

Drug NameEIS-12656
Drug Alias NameEIS-12656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChromodomain-helicase-DNA-binding protein 1-like inhibitors
TargetsChromodomain-helicase-DNA-binding protein 1-like
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEisbach Bio GmbH
China Registration ClassN/A

Develop Information

Active CompaniesEisbach Bio GmbH
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A